Assuntos
Antibacterianos/uso terapêutico , Úlcera Duodenal/tratamento farmacológico , Dispepsia/tratamento farmacológico , Fármacos Gastrointestinais/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Úlcera Gástrica/tratamento farmacológico , Quimioterapia Combinada , Úlcera Duodenal/diagnóstico , Úlcera Duodenal/microbiologia , Dispepsia/diagnóstico , Dispepsia/microbiologia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/diagnóstico , Helicobacter pylori/isolamento & purificação , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Úlcera Gástrica/diagnóstico , Úlcera Gástrica/microbiologia , Resultado do TratamentoRESUMO
Lifestyle changes and some drugs can help. Lifestyle interventions aimed at weight loss of 5% to 10% of body weight along with moderate aerobic exercise such as brisk walking for 150 minutes a week are the most effective means to prevent impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) from progressing to diabetes (strength of recommendation [SOR]: A, several meta-analyses, including a recent Cochrane review).
Assuntos
Diabetes Mellitus Tipo 2/prevenção & controle , Intolerância à Glucose/complicações , Acarbose/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Progressão da Doença , Humanos , Hipoglicemiantes/uso terapêutico , Estilo de Vida , Estado Pré-Diabético/diagnóstico , Rosiglitazona , Tiazolidinedionas/uso terapêutico , Redução de PesoRESUMO
For mild comedonal acne, monotherapy with topical retinoids is the treatment of choice (strength of recommendation [SOR]: A). For moderate comedonal and mild to moderate papulopustular acne, combination therapy with either benzoyl peroxide or topical retinoids (adapalene [Differin], tazarotene [Tazorac], tretinoin [Retin-A]) plus topical antibiotics (erythromycin or clindamycin) is proven most effective (SOR: A). Six to 8 weeks should be allowed for most treatments to work before altering the regimen (SOR: A).
Assuntos
Acne Vulgar/tratamento farmacológico , Antibacterianos/uso terapêutico , Peróxido de Benzoíla/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Retinoides/uso terapêutico , Clindamicina/uso terapêutico , Quimioterapia Combinada , Eritromicina/uso terapêutico , HumanosAssuntos
Dermatite Atópica/tratamento farmacológico , Imunossupressores/uso terapêutico , Tacrolimo/análogos & derivados , Tacrolimo/uso terapêutico , Administração Tópica , Análise Custo-Benefício , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/economia , Tacrolimo/efeitos adversos , Tacrolimo/economiaRESUMO
OBJECTIVES: We examined the published literature on health programs in faith-based organizations to determine the effectiveness of these programs. METHODS: We conducted a systematic literature review of articles describing faith-based health activities. Articles (n = 386) were screened for eligibility (n = 105), whether a faith-based health program was described (n = 53), and whether program effects were reported (28). RESULTS: Most programs focused on primary prevention (50.9%), general health maintenance (25.5%), cardiovascular health (20.7%), or cancer (18.9%). Significant effects reported included reductions in cholesterol and blood pressure levels, weight, and disease symptoms and increases in the use of mammography and breast self-examination. CONCLUSIONS: Faith-based programs can improve health outcomes. Means are needed for increasing the frequency with which such programs are evaluated and the results of these evaluations are disseminated.
